Le Lézard
Classified in: Business, Covid-19 virus
Subjects: MAV, ECO, CFG

/R E P E A T -- Invitation to media - Minister Mélanie Joly to announce support for Quebec's innovation sector/


MONTRÉAL, July 10, 2020 /CNW Telbec/ -  Canada Economic Development for Quebec Regions (CED)

The Honourable Mélanie Joly, Minister of Economic Development and Official Languages, accompanied by Élisabeth Brière, Member of Parliament for Sherbrooke and Parliamentary Secretary to the Minister for the Economic Development Agency of Canada for the Regions of Quebec, will announce Government of Canada financial support to boost the growth of more than 40 innovative Quebec businesses and organizations.

For many years now, the Government of Canada has been committed to stimulating growth by supporting innovative projects and working in synergy with Quebec's business incubators and accelerators.

Date:
July 13, 2020

Time:
10:30 a.m.

Location:
Centre Phi
Espace A
407 rue Saint-Pierre
Montréal, Quebec
H2Y 2M3

Journalists must confirm their participation by sending their full name and the name of their media outlet to the following email address by 9 a.m. on Monday, July 13, 2020: [email protected], also specifying if they will be on site or connecting from a distance to attend the press conference virtually. For those connecting from a distance, a Zoom link will be sent to enable them to ask questions following the press briefing.

The press briefing will also be broadcast on CED's Twitter account.

Anyone attending the press conference must not present any symptoms similar to those of COVID-19 and must not have been in contact with anyone who has received a positive diagnosis within the last 14 days. Note that the wearing of face masks is strongly recommended.

Stay connected

Follow CED on social media
Consult CED's news

SOURCE Canada Economic Development for Quebec Regions


These press releases may also interest you

at 09:35
Two Clinical Trials Identify a Better Way to Target Appropriate Antibiotics for Patients Hospitalized With Pneumonia or Urinary Tract Infection
Two large multi-state studies uncovered a highly effective way to improve antibiotic selection for patients hospitalized with pneumonia or urinary tract infections (UTI), enabling better antibiotic stewardship in hospitals, according to research...

at 09:25
United States Telehealth Weight Loss Market Report 2024-2028: Impacts of COVID and GLP-1 Meds Featuring Weight Watchers, Noom, Ro.co, , AmWell, Amazon, Teladoc, Form Health, Form Health Among Others - ResearchAndMarkets.com
The "The U.S. Telehealth Weight Loss Market" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering The report includes in-depth analyses of: the scope of telehealth usage in the U.S., telehealth user demographics, pros and...

at 09:00
Inaugural 'Korea Medical Innovation Research Forum' regular seminar, a success
Amid growing concerns about a medical crisis as a result of acute conflict between the government...

at 08:45
Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against QuidelOrtho Corporation
Wolf Haldenstein Adler Freeman & Herz LLP  ("Wolf  Haldenstein") announces that a federal securities class action lawsuit has been filed in the United States District Court for the Southern  District of New York on behalf of investors who purchased...

at 08:00
Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R)
Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals, is happy to announce that its wholly owned generic pharmaceutical subsidiary, Nora...

at 07:00
DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against QuidelOrtho Corporation ("QuidelOrtho" or "the Company") for violations of 10(b) and 20(a) of the Securities...

More news about Covid-19 virus...


News published on and distributed by: